Literature DB >> 31640517

Beyond drugs: the evolution of genes involved in human response to medications.

Silvia Fuselli1.   

Abstract

The genetic variation of our species reflects human demographic history and adaptation to diverse local environments. Part of this genetic variation affects individual responses to exogenous substances, such as food, pollutants and drugs, and plays an important role in drug efficacy and safety. This review provides a synthesis of the evolution of loci implicated in human pharmacological response and metabolism, interpreted within the theoretical framework of population genetics and molecular evolution. In particular, I review and discuss key evolutionary aspects of different pharmacogenes in humans and other species, such as the relationship between the type of substrates and rate of evolution; the selective pressure exerted by landscape variables or dietary habits; expected and observed patterns of rare genetic variation. Finally, I discuss how this knowledge can be translated directly or after the implementation of specific studies, into practical guidelines.

Entities:  

Keywords:  drug-metabolizing enzymes; evolution; natural selection; pharmacogenomics; rare genetic variants

Mesh:

Substances:

Year:  2019        PMID: 31640517      PMCID: PMC6834052          DOI: 10.1098/rspb.2019.1716

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  97 in total

1.  Pooled association tests for rare variants in exon-resequencing studies.

Authors:  Alkes L Price; Gregory V Kryukov; Paul I W de Bakker; Shaun M Purcell; Jeff Staples; Lee-Jen Wei; Shamil R Sunyaev
Journal:  Am J Hum Genet       Date:  2010-05-13       Impact factor: 11.025

2.  An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people.

Authors:  Matthew R Nelson; Daniel Wegmann; Margaret G Ehm; Darren Kessner; Pamela St Jean; Claudio Verzilli; Judong Shen; Zhengzheng Tang; Silviu-Alin Bacanu; Dana Fraser; Liling Warren; Jennifer Aponte; Matthew Zawistowski; Xiao Liu; Hao Zhang; Yong Zhang; Jun Li; Yun Li; Li Li; Peter Woollard; Simon Topp; Matthew D Hall; Keith Nangle; Jun Wang; Gonçalo Abecasis; Lon R Cardon; Sebastian Zöllner; John C Whittaker; Stephanie L Chissoe; John Novembre; Vincent Mooser
Journal:  Science       Date:  2012-05-17       Impact factor: 47.728

3.  Human adaptation to arsenic-rich environments.

Authors:  Carina M Schlebusch; Lucie M Gattepaille; Karin Engström; Marie Vahter; Mattias Jakobsson; Karin Broberg
Journal:  Mol Biol Evol       Date:  2015-03-03       Impact factor: 16.240

Review 4.  Copy number variants in pharmacogenetic genes.

Authors:  Yijing He; Janelle M Hoskins; Howard L McLeod
Journal:  Trends Mol Med       Date:  2011-03-08       Impact factor: 11.951

Review 5.  Treatment resistance in urothelial carcinoma: an evolutionary perspective.

Authors:  Panagiotis J Vlachostergios; Bishoy M Faltas
Journal:  Nat Rev Clin Oncol       Date:  2018-08       Impact factor: 66.675

6.  Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.

Authors:  C H van der Wouden; A Cambon-Thomsen; E Cecchin; K C Cheung; C L Dávila-Fajardo; V H Deneer; V Dolžan; M Ingelman-Sundberg; S Jönsson; M O Karlsson; M Kriek; C Mitropoulou; G P Patrinos; M Pirmohamed; M Samwald; E Schaeffeler; M Schwab; D Steinberger; J Stingl; G Sunder-Plassmann; G Toffoli; R M Turner; M H van Rhenen; J J Swen; H-J Guchelaar
Journal:  Clin Pharmacol Ther       Date:  2017-03       Impact factor: 6.875

7.  Differential susceptibility to hypertension is due to selection during the out-of-Africa expansion.

Authors:  J Hunter Young; Yen-Pei C Chang; James Dae-Ok Kim; Jean-Paul Chretien; Michael J Klag; Michael A Levine; Christopher B Ruff; Nae-Yuh Wang; Aravinda Chakravarti
Journal:  PLoS Genet       Date:  2005-12-30       Impact factor: 5.917

8.  Comparison of carnivore, omnivore, and herbivore mammalian genomes with a new leopard assembly.

Authors:  Soonok Kim; Yun Sung Cho; Hak-Min Kim; Oksung Chung; Hyunho Kim; Sungwoong Jho; Hong Seomun; Jeongho Kim; Woo Young Bang; Changmu Kim; Junghwa An; Chang Hwan Bae; Youngjune Bhak; Sungwon Jeon; Hyejun Yoon; Yumi Kim; JeHoon Jun; HyeJin Lee; Suan Cho; Olga Uphyrkina; Aleksey Kostyria; John Goodrich; Dale Miquelle; Melody Roelke; John Lewis; Andrey Yurchenko; Anton Bankevich; Juok Cho; Semin Lee; Jeremy S Edwards; Jessica A Weber; Jo Cook; Sangsoo Kim; Hang Lee; Andrea Manica; Ilbeum Lee; Stephen J O'Brien; Jong Bhak; Joo-Hong Yeo
Journal:  Genome Biol       Date:  2016-10-11       Impact factor: 13.583

9.  Multiple advantageous amino acid variants in the NAT2 gene in human populations.

Authors:  Francesca Luca; Giuseppina Bubba; Massimo Basile; Radim Brdicka; Emmanuel Michalodimitrakis; Olga Rickards; Galina Vershubsky; Lluis Quintana-Murci; Andrey I Kozlov; Andrea Novelletto
Journal:  PLoS One       Date:  2008-09-05       Impact factor: 3.240

10.  Using high-resolution variant frequencies to empower clinical genome interpretation.

Authors:  Nicola Whiffin; Eric Minikel; Roddy Walsh; Anne H O'Donnell-Luria; Konrad Karczewski; Alexander Y Ing; Paul J R Barton; Birgit Funke; Stuart A Cook; Daniel MacArthur; James S Ware
Journal:  Genet Med       Date:  2017-05-18       Impact factor: 8.822

View more
  3 in total

1.  Idiopathic Symptoms Resolved by Pharmacogenomics-Enriched Comprehensive Medication Management: A Case Report.

Authors:  April Prather; Aissa Aifaoui; Jeffrey A Shaman
Journal:  Cureus       Date:  2022-02-02

2.  Fly immunity comes of age: The utility of Drosophila as a model for studying variation in immunosenescence.

Authors:  Mary-Kate Corbally; Jennifer C Regan
Journal:  Front Aging       Date:  2022-10-04

3.  Genomic Copy Number Variation Study of Nine Macaca Species Provides New Insights into Their Genetic Divergence, Adaptation, and Biomedical Application.

Authors:  Jing Li; Zhenxin Fan; Feichen Shen; Amanda L Pendleton; Yang Song; Jinchuan Xing; Bisong Yue; Jeffrey M Kidd; Jing Li
Journal:  Genome Biol Evol       Date:  2020-12-06       Impact factor: 3.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.